Sophie Seang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Prognostic Factors

Antiretroviral Therapy

Hiv Infected Patients

Randomized Controlled Trial

Top Venues

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Baptiste Sellem, Basma Abdi, Minh Lê, Roland Tubiana, Marc-Antoine Valantin, Sophie Seang, Luminita Schneider, Antoine Fayçal, Gilles Peytavin, Cathia Soulié, Anne Geneviève Marcelin, Christine Katlama, Valérie Pourcher, Romain Palich
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV. Journal of personalized medicine 13 (4) (2023)
Baptiste Sellem, Basma Abdi, Minh Lê, Roland Tubiana, Marc-Antoine Valantin, Sophie Seang, Luminita Schneider, Antoine Fayçal, Gilles Peytavin, Cathia Soulié, Anne Geneviève Marcelin, Christine Katlama, Valérie Pourcher, Romain Palich
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV. Journal of personalized medicine 13 (4) (2023)
Baptiste Sellem, Basma Abdi, Minh Lê, Roland Tubiana, Marc-Antoine Valantin, Sophie Seang, Luminita Schneider, Antoine Fayçal, Gilles Peytavin, Cathia Soulié, Anne Geneviève Marcelin, Christine Katlama, Valérie Pourcher, Romain Palich
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV. Journal of personalized medicine 13 (4) (2023)